Howard Colman

University of Utah

Associate Professor(heuristic)Rising Star

Cancer Genomics and Diagnostics · Cancer Research

Compare more Cancer Research professors.

h-index14
i10-index14
Publications18
Citations17,462

Grants

1 total · 1 active

NIH #R01CA300362

Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma

Active
Amount
$600K–$700K
Period
2026-04-01 → 2031-03-31
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

1 total · 1 active

NIH #R01CA300362

Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma

Active
Amount
$600K–$700K
Period
2026-04-01 → 2031-03-31
PIs
2

Awarded at UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH

Recent Public Signals

  1. New NIH award: Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma2026-04-01
  2. New paper: New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study (Diabetes Obesity and Metabolism)2025-11-24

Rising Star

  • 8 years into career
  • 0% publication growth YoY
  • 133% citation growth YoY
  • 0% centrality growth YoY
  • 1 active grants

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Professor Insights

Career Trajectory